Reversing Type 2 Diabetes Through Low-Carb Diet and Lifestyle Changes

Key Quotes

"only one in eight of the population is metabolically healthy one in eight so in our practice of all the people who have diabetes we know that if they go low carb 50 of them will achieve drug free type two diabetes remission at three years further 48 have improved their blood sugar significantly or maybe they're on less medication it's amazing because the average improvements are better than drugs for diabetes"

Dr. Rangan Chatterjee introduces Dr. David Unwin's practice data, highlighting the significant success rate of patients achieving drug-free type 2 diabetes remission or improved blood sugar control through a low-carb approach. This statistic suggests that lifestyle interventions can be more effective than conventional medication for managing diabetes.

"And this is a serious issue because poor metabolic health is one of the root cause drivers of insulin resistance, type two diabetes, cardiovascular disease, strokes, Alzheimer’s and many forms of cancer."

Dr. Chatterjee emphasizes the widespread impact of poor metabolic health, identifying it as a foundational cause for a range of serious chronic diseases. This underscores the importance of addressing metabolic health proactively to prevent a cascade of health problems.

"The first thing is I used to find myself tired particularly after meals so I remember after lunch even in the practice I'd have to have a little nap on my own doctor's couch isn't that terrible and I was only 55 I and I thought that was aging so the first thing is tiredness particularly after meals and also I was always ready to lie down in the evening I was always thinking I'd put my feet up instead of doing anything that's one thing"

Dr. David Unwin shares his personal experience with early signs of poor metabolic health, describing post-meal fatigue and evening lethargy as symptoms he initially attributed to normal aging. This personal anecdote illustrates how common symptoms can be overlooked as indicators of underlying metabolic issues.

"And my insulin wasn't working properly I mean and then you have the various biochemical tests that doctors might do so uh any sign of fatty liver well maybe we'll come on to that a third of everybody in the world now has fatty liver so I had that as well"

Dr. Unwin connects his personal symptoms to the physiological issue of insulin resistance and mentions fatty liver as another common biochemical marker associated with poor metabolic health. He highlights that conditions like fatty liver are widespread, suggesting a systemic problem with metabolic regulation.

"And my insulin wasn't working properly I mean and then you have the various biochemical tests that doctors might do so uh any sign of fatty liver well maybe we'll come on to that a third of everybody in the world now has fatty liver so I had that as well"

Dr. Unwin connects his personal symptoms to the physiological issue of insulin resistance and mentions fatty liver as another common biochemical marker associated with poor metabolic health. He highlights that conditions like fatty liver are widespread, suggesting a systemic problem with metabolic regulation.

"And I believe there's something very peculiar about that I'm it's interesting because I i lecture at edge hill university sometimes I'm an honorary lecture in medical ethics and it is so odd that we're doing things to patients without explaining the pros and cons and how is it that we're exempt from giving people that vital information for for like say metformin I know that approximately a third of people given metformin over 10 years will find them get diarrhea like that lady and yet I didn't have to tell her it's odd isn't it why do you think that is so peculiar"

Dr. Chatterjee expresses concern about the lack of informed consent regarding lifelong medications like metformin, noting that patients are often not fully informed about potential side effects. He finds this practice peculiar, especially in contrast to the detailed consent required for minor procedures.

"So I remember a time when I was little when most people were were fit I didn't know anybody with type two diabetes or asthma I didn't know any children or young people with depression the world was so different and I I think we're beginning to normalize chronic ill health and the danger of that"

Dr. Unwin reflects on a past era where chronic illnesses like type 2 diabetes and depression were less prevalent among the general population. He expresses concern that society is becoming desensitized to these conditions, normalizing what was once considered abnormal.

"So I remember a time when I was little when most people were were fit I didn't know anybody with type two diabetes or asthma I didn't know any children or young people with depression the world was so different and I I think we're beginning to normalize chronic ill health and the danger of that"

Dr. Unwin reflects on a past era where chronic illnesses like type 2 diabetes and depression were less prevalent among the general population. He expresses concern that society is becoming desensitized to these conditions, normalizing what was once considered abnormal.

"So I remember a time when I was little when most people were were fit I didn't know anybody with type two diabetes or asthma I didn't know any children or young people with depression the world was so different and I I think we're beginning to normalize chronic ill health and the danger of that"

Dr. Unwin reflects on a past era where chronic illnesses like type 2 diabetes and depression were less prevalent among the general population. He expresses concern that society is becoming desensitized to these conditions, normalizing what was once considered abnormal.

"So I remember a time when I was little when most people were were fit I didn't know anybody with type two diabetes or asthma I didn't know any children or young people with depression the world was so different and I I think we're beginning to normalize chronic ill health and the danger of that"

Dr. Unwin reflects on a past era where chronic illnesses like type 2 diabetes and depression were less prevalent among the general population. He expresses concern that society is becoming desensitized to these conditions, normalizing what was once considered abnormal.

"So I remember a time when I was little when most people were were fit I didn't know anybody with type two diabetes or asthma I didn't know any children or young people with depression the world was so different and I I think we're beginning to normalize chronic ill health and the danger of that"

Dr. Unwin reflects on a past era where chronic illnesses like type 2 diabetes and depression were less prevalent among the general population. He expresses concern that society is becoming desensitized to these conditions, normalizing what was once considered abnormal.

"So I remember a time when I was little when most people were were fit I didn't know anybody with type two diabetes or asthma I didn't know any children or young people with depression the world was so different and I I think we're beginning to normalize chronic ill health and the danger of that"

Dr. Unwin reflects on a past era where chronic illnesses like type 2 diabetes and depression were less prevalent among the general population. He expresses concern that society is becoming desensitized to these conditions, normalizing what was once considered abnormal.

"So I remember a time when I was little when most people were